About Celiac Diseaseceliac kjøpe.

About Celiac Diseaseceliac. is a T-cell -mediated autoimmune disease that occurs in genetically susceptible individuals and is caused by small in intestinal inflammation, injury and intolerance to gluten. According to the National Institutes of Health, has CD about 3 million Americans kjøpe . Currently, the only treatment for CD is complete elimination of gluten from the diet, remission in some remission in some patients.

Alba Therapeutics Announces Phase IIb clinical trial for Oral AT-1001 for the treatment of celiac diseaseAlba Therapeutics Corporation announced today that its first patient dosed in a six-week phase IIb trial with oral AT-1001 one inhibitor of gastrointestinal barrier dysfunction, for the maintenance of remission in patients with celiac disease . The multicenter, double-blind, placebo-controlled, is dose-finding study evaluating the efficacy, safety and tolerability of AT-1001 in CD subjects during a six-week gluten challenge and test components of celiac disease activity rating index, a new patient – reported outcomes instrument. ‘This is Alba fifth study on people with AT-1001 and highlights our paradigms paradigms for the treatment of CD and for the assessment of activity in this neglected disease,’said Dr. Blake Paterson, CEO of Alba. ‘Since there is no effective treatment for CD and no validated instrument to measure disease progression, T cell successful completion of this study be a huge step forward for celiacs ‘.

Current ‘agency of the future ‘is a functional environment can also improve loss of weight and maintenance of health.

Other entries from category "treatments":

Random entries